Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: rheumatoid arthritis + rheumatoid arthritis: + arthritis  Related to the article below (Last Update: 8/5/2008)

Stroke rehab may be poorer for arthritis patients
Reuters UK, UK -
By Michelle Rizzo NEW YORK (Reuters Health) - People with rheumatoid arthritis who suffer a stroke are likely to have lower functional ability subsequently ...
Behavioral Comorbidities in Rheumatoid Arthritis
Psychiatric Times, NY -
While tremendous therapeutic advancements have been made, patients with rheumatoid arthritis (RA) have a myriad of comorbidities, including fatigue, ...

ChattahBox
FDA Panel Backs Rheumatoid-Arthritis Drug
Wall Street Journal - Jul 29, 2008
By JARED A. FAVOLE WASHINGTON -- A panel of medical experts on Tuesday backed Roche Holding AG's rheumatoid arthritis drug Actemra, despite safety concerns ...
Roche wins US panel support for arthritis drug Reuters
2nd UPDATE: FDA Panel Backs Roche Athritis Drug Actemra CNNMoney.com
FDA Panel Backs Roche Rheumatoid Arthritis Drug, Actemra dBTechno
eFluxMedia - MarketWatch
all 147 news articles »  OTC:RHHBY - SWF:RO - SWF:HUE
In Good Health ? Respect your elders ... keep them cool
Frederick News Post (subscription), MD -
The Arthritis & Osteoporosis Center of Maryland is looking for volunteers to participate in a study of an investigational drug for rheumatoid arthritis. ...

Oneindia
Arthritis May Double Heart Attack
Oneindia, India - Jul 31, 2008
Patients with rheumatoid arthritis are twice as likely to suffer a heart attack, suggests a new study. Rheumatoid arthritis, lupus, and related autoimmune ...
Joint Inflammation and Heart Disease Linked Newswise (press release)
all 12 news articles »

BBC News
UK?s Nice Nixes Second Tries With Rheumatoid Arthritis Meds
Wall Street Journal Blogs, NY - Jul 21, 2008
... try with another one of several big-selling drugs for rheumatoid arthritis after a patient has failed treatment with a different medicine in the class. ...
Outcry at Government drug watchdog's plan to cut arthritis treatments Telegraph.co.uk
Restricting arthritis drugs ?a prescription for pain? Times Online
Arthritis drug access 'curbed' BBC News
The Press Association - Reuters
all 151 news articles »
FDA: Roche's Actemra Appears Effective in Rheumatoid Arthritis
Wall Street Journal - Jul 25, 2008
By JARED A. FAVOLE and ANITA GREIL Roche Holding AG's Actemra appears effective at treating rheumatoid arthritis, a disease that can destroy joints and ...
Roche arthritis drug works: FDA staff Reuters
Place Your Biotech Bets Motley Fool
Roche arthritis drug works - US FDA staff Forbes
Reuters
all 26 news articles »  OTC:RHHBY - SWF:RO - SWF:HUE
*ROCHE: FDA COMMITTEE RECOMMENDS ACTEMRA FOR TREATMENT OF ...
華富財經, Hong Kong - Jul 29, 2008
In relation to the stock quote service (the "Quote Service") information, the stock price, trade volume and turnover are provided by The Stock Exchange of ...
Training in high temperatures
Cyclingnews.com -
I have read the answer to a question in 2005 but it related to Rheumatoid Arthritis and so am not sure whether it is applicable.

eFluxMedia
Drug Combo Improves Remission of Rheumatoid Arthritis
Washington Post, United States - Jul 16, 2008
WEDNESDAY, July 16 (HealthDay News) -- Patients with moderate-to-severe rheumatoid arthritis benefited from combining the drugs methotrexate and Enbrel ...
Data Demonstrated Benefits of Early Treatment in Patients with ... MarketWatch
Drug Makers: Trial Shows Combination Therapy Helps Arthritis CNNMoney.com
Amgen's Enbrel Drug Works in Early-Stage Arthritis, Study Finds Bloomberg
Medical News Today - eFluxMedia
all 39 news articles »  AMGN
Source: Google News

… American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis -
FC Arnett, SM Edworthy, DA Bloch, DJ McShane, JF … - Arthritis Rheum, 1988 - ncbi.nlm.nih.gov
Arthritis Rheum. 1988 Mar;31(3):315-24. The American Rheumatism Association 1987
revised criteria for the classification of rheumatoid arthritis. ...

… of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis -
C Bombardier, L Laine, A Reicin, D Shapiro, R … - New England Journal of Medicine, 2000 - content.nejm.org
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients
with Rheumatoid Arthritis. ... Therapeutic Strategies for Rheumatoid Arthritis. ...

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis -
PE Lipsky, DMFM van der Heijde, EW St Clair, DE … - New England Journal of Medicine, 2000 - content.nejm.org
... Next Next. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis.
Peter E. Lipsky, MD, Desiree MFM van der Heijde, MD, E. William St. ...

… monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. -
MJ Elliott, RN Maini, M Feldmann, JR Kalden, C … - Lancet, 1994 - ncbi.nlm.nih.gov
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis
factor alpha (cA2) versus placebo in rheumatoid arthritis. ...

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc … -
LW Moreland, SW Baumgartner, MH Schiff, EA Tindall … - New England Journal of Medicine, 1997 - content.nejm.org
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor
Receptor (p75)?Fc Fusion Protein. ... New Drugs for Rheumatoid Arthritis. ...

… vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis The CLASS Study … -
FE Silverstein, G Faich, JL Goldstein, LS Simon, T … - JAMA, 2000 - Am Med Assoc
... JAMA-EXPRESS Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal
Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis ...

… alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant … -
R Maini, EW StClair, F Breedveld, D Furst, J … - Lancet, 1999 - informedpharmacotherapy.com
... Infliximab in rheumatoid arthritis: An ATTRACTive option? ... Patients in all arms
had recalcitrant rheumatoid arthritis of comparable severity. ...

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis -
JM Bathon, RW Martin, RM Fleischmann, JR Tesser, … - New England Journal of Medicine, 2000 - content.nejm.org
... A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis. ...
Tumor Necrosis Factor Inhibitor Therapy for Rheumatoid Arthritis. ...

… . An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. -
PK Gregersen, J Silver, RJ Winchester - Arthritis Rheum, 1987 - ncbi.nlm.nih.gov
1987 Nov;30(11):1205-13. The shared epitope hypothesis. An approach to understanding
the molecular genetics of susceptibility to rheumatoid arthritis. ...

… for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis -
DT Felson, JJ Anderson, M Boers, C Bombardier, M … - Arthritis Rheum, 1993 - ncbi.nlm.nih.gov
1993 Jun;36(6):729-40. The American College of Rheumatology preliminary core set
of disease activity measures for rheumatoid arthritis clinical trials. ...

Source: Google Scholar
 

Rheumatoid Arthritis

About 2.1 million Americans have rheumatoid arthritis. Rheumatoid arthritis is one of more than 100 forms of arthritis. It is a chronic (ongoing) condition in which the synovium (the tissue that lines and lubricates the joints) becomes inflamed. Large and small joints, as well as both sides of the body, are usually affected. Over time, the joints become deformed and knotted-looking if the disease is not treated properly. However, modern treatment and early recognition of the disease has led to fewer deformities and a much better outlook.

Symptoms and Signs

The symptoms of rheumatoid arthritis tend to come and go. Periods of severe symptoms (flare-ups) will be followed by periods when the symptoms of rheumatoid arthritis are nearly gone. While rheumatoid arthritis can begin suddenly, it usually appears gradually and affects the smaller joints of the body, such as the fingers and toes. The main symptom is pain, and the major sign of the disease is tenderness in nearly all inflamed joints. Eventually, the synovial lining inside the joint becomes thicker.

Article continues below and (thank you)

 

If a joint on one side of the body is affected, usually the same joint on the other side of the body will also be affected. For example, if the left wrist is inflamed, the right one usually is, too. It usually affects the hands, feet, wrists, elbows and ankles, but it can occur in any joint, even the neck.

Other symptoms or signs include:

  • A low-grade fever
  • Changes in appearance of the joints
  • Difficulty sleeping because of the pain
  • Feeling tired, fatigued or unwell in the early afternoon
  • Inflammation of the tear glands, salivary glands, linings of the heart and lung, lungs and (in rare cases) the blood vessels. These are more rare today with modern treatment and early recognition of the disease.
  • Small lumps (rheumatoid nodules) that form under the skin at pressure points, such as the elbows, hands, feet and Achilles tendons. They may also occur in other places, such as the back of the scalp or in the lungs. These nodules can range from being as small as a pea to as large as a walnut. They usually do not hurt.
  • Stiffness that lasts 45 minutes or more when getting up in the morning or after a period of not moving
Causes and Risk Factors

Unlike osteoarthritis, which results from wear and tear on the joints, rheumatoid arthritis is an inflammatory condition. The cause of rheumatoid arthritis is not known. Some researchers suspect that rheumatoid arthritis is triggered by an infection in people who have inherited the tendency to develop rheumatoid arthritis. Other environmental factors are currently being examined as triggers, such as prior exposure to immunizations, medications, etc. Other researchers believe that hormones may play a role in the development or severity of rheumatoid arthritis. We already know that smoking is a risk factor for rheumatoid arthritis susceptibility as well as severity. Women are two to three times more likely than men to develop rheumatoid arthritis. It can develop at any age, but it most often occurs in people between the ages of 25 and 50.

The inflammation and damage to the joints may be a result of the body's immune attacking the joints as if they were foreign bodies. White blood cells, which normally attack bacteria or viruses, move from the bloodstream into the synovium, making it swell and become tender. This inflammation causes proteins to be released that over months and years make the synovium grow thicker. These proteins also damage cartilage, bone, tendons and ligaments. In time, if treatment is not instituted promptly, the joint loses its shape and the bones no longer line up correctly.

Diagnosis

To diagnose rheumatoid arthritis, a doctor will perform a physical examination and discuss the symptoms. If arthritis of any kind is suspected, the patient is referred to a rheumatologist, a specialist who is trained to recognize and treat rheumatoid arthritis, as well as other kinds of arthritis. There are a number of forms of arthritis, and each must be considered and ruled out before a diagnosis can be made. Additionally, conditions like lupus, sarcoidosis, amyloidosis, ankylosing spondylitis and Whipple's disease can mimic rheumatoid arthritis. The doctor may order the following tests:

  • Blood tests. These may show a higher than normal level of antibodies called rheumatoid factors. (Higher levels of these factors are also found in a number of other chronic conditions, and a positive test does not necessarily mean rheumatoid arthritis.)
  • Samples of synovial fluid.
  • X-rays. During the first months of the disease, only the swelling of the soft tissues around the joint can be seen. As the disease condition progresses, there may be a narrowing of the space in which the joints move and damage to the ends of the bones.
  • Magnetic resonance imaging (MRI). This test may be used early in the course of the disease to help make a diagnosis and separate the condition (rheumatoid arthritis) from other possible problems that affect the bones and joints.
Treatment

During the first year after a diagnosis, three out of four people with rheumatoid arthritis will require a more aggressive approach with drugs that can effectively eliminate pain, reduce functional disability and prevent damage to the joints. Rheumatologists typically use combinations of drugs, even including new agents that have been developed through research into the molecular mechanisms that cause joint inflammation.

Some patients (a minority) will be managed effectively with anti-inflammatory drugs only or local injections of cortisone into the joints. A determination of the risk for disease progression is important for your rheumatologist to make because this assessment will guide therapeutic decisions. In addition to management of the disease with medications, a number of important maneuvers and adjunctive approaches can be employed, including:

  • Assistive devices that can help relieve stress on your joints
    Complete bed rest when the condition is most active and painful. Regular rest may be needed in less severe cases.
  • Diet
  • Drug therapy
  • Exercise
  • Joint injections or aspiration
  • Making lifestyle changes that can ease the condition
  • Managing pain
  • Physical rehabilitation
If medical approaches do not control the symptoms, surgery may be needed. Available surgical procedures include:
  • Arthroscopic synovectomy
  • Arthroplasty, in which parts of the joint are replaced with artificial parts. This may be done if there is joint damage that limits the movement of the joint
  • Total joint replacement. This is typically done with the hip and knee
  • Fusion of joints, so that the damaged parts are not moving against each other
 
 
 
Google
Web www.iconocast.com
 
 
ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast